EGG DROP SYNDROME VACCINE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

AVIAN HAEMAGLUTINATING VIRUS - KILLED; FORMALDEHYDE

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

vaccine - egg drop syndrome(I)

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

AVIAN HAEMAGLUTINATING VIRUS - KILLED VACCINE-VIRAL Active 0.0 P; FORMALDEHYDE ALDEHYDE Other 100.0 ppm

Units in package:

#(1000; #500mL; #doses)

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

POULTRY | BREEDERS | BROILER | CHICKENS | CHICKS | CHOOKS | DAY OLD CHICKS | HATCHLINGS | LAYERS

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

AVIAN HAEMAGGLUTINATING ADENOVIRUS | ADENOVIRUS | EGG DROP SYNDROME

Product summary:

Poison schedule: 0; Withholding period: WHP: EGGS: NIL MEAT: DO NOT USE less t han 10 weeks before slaughter for human consumption.; Host/pest details: POULTRY: [AVIAN HAEMAGGLUTINATING ADENOVIRUS]; Poison schedule: 0; Withholding period: ; Host/pest details: POULTRY: [AVIAN HAEMAGGLUTINATING ADENOVIRUS]; For use in the prevention of egg production drops in fowls associated with avian haemaglutinating adenovirus.Not recommended for use in birds in or approaching lay (within 3 weeks).

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

FOR
ANIMAL
TREATMENT
ONLY
Egg Drop Syndrome Vaccine -
Vaccine Label
Version 6
Egg
Drop
Syndrome
Vaccine
Active
Constituent
Killedavian haemagglutinating adenovirus
(Ref:
J8036/1)
emulsified with a paraffin-oil
adjuvant.
Contains no greater than
ten-ppm
formaldehyde as a preservative. End of shelf
life potency: Mean antibody titre is equal
to or
greater than 1:128 using HI testing
or
Guildhay EOS EIA assay.
For use in the prevention of egg production
drops in fowls associated with infection with
avian haemagglutinating adenovirus.
DIRECTIONS FOR USE
Note: Not
recommended for use in birds in
or
approaching
lay.
1) Invert
the container several
times prior to
use in order
10
achieve a uniform suspension
of vaccine.
2)
Use
all
vaccine within 8 hours of opening.
3) 0.5 mL per dose
4) Administer
by
intramuscular injection into
the breast muscle.
5) Vaccinate birds from 12 to 18 weeks old.
It
is not recommended that
birds be vaccinated
within 3
weeks
of commencement of lay.
In
itself,
such a procedure is not expected to
harm the birds in any way.
but
the handling of
birds close to or
in lay can disrupt egg
production.
Caution:
avoid
carcass
damage
6) Sterilise all
injection apparatus
by
boiling
before use.
Avoid use of strong disinfectants
on apparatus.
7) Maintain cleanliness
at
all
times.
8) Keep needles sharp and clean.
Replace
frequently.
9) Use needles of appropriate gauge and
length.
10) As far as possible avoid injection of wet
or heavily soiled animals.
11) This product must
be injected only into
muscle tissue.
12) Inject
into breast muscle only.
WITHHOLDING PERIOD,
EGGS:
NIL
MEAT:
DO NOT USE less than 10 weeks
before slaughter for human consumption.
STORAGE
Store between
2'C
and 8"C
(Refrigerate.
Do not freeze).
DISPOSAL INSTRUCTIONS:
Dispose of empty container by wrapping with
paper and putting in garbage.
Discarded needles
&
sharps should be
immediately placed
in a designated and
appropriately labeled
'sharps'
container.
SAFETY DIRECTIONS:
If accidental
self-
inoculation occurs seek immediate medical
advice as

Summary of Product characteristics

PRODUCT NAME: EGG DROP SYNDROME VACCINE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Haemagglutinating Avian Adenovirus in an oil/water emulsion with other
minor
ingredients.
TRADE NAME:
EGG DROP SYNDROME VACCINE
PRODUCT CODE:
16901
RECOMMENDED USE:
For use in the prevention of egg production drops in fowls associated
with avian
haemaglutinating adenovirus.
APVMA NO:
39915
CREATION DATE:
February, 2007
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23, S37, S24/25. Do not breathe mists. Wear suitable gloves. Avoid
contact with skin and eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Whit to off-white liquid emulsion.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be mildly irritating, but is unlikely
to cause anything more than mild discomfort which
should disappear once contact ceases.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin ex